October 15th is nearly here – Help us Spread the Word about Global Lobular Breast Cancer Awareness Day
The first Global Lobular Breast Cancer Awareness Day is less than 2 months away on Oct. 15th! Help us declare this awareness day for Lobular […]
Home Page
LBCA Declares October 15th Global Lobular Breast Cancer Awareness Day
Click Here to Read the Global Declaration Letter The Lobular Breast Cancer Alliance (LBCA), a US nonprofit organization whose mission is to raise awareness and
LBCA Declares October 15th Global Lobular Breast Cancer Awareness Day Read More »
LBCA Board Runs and Remembers Deb Mueller
October is Breast Cancer Awareness Month, and there is still such a huge need to make everyone aware of invasive lobular carcinoma (ILC), its troubling
LBCA Board Runs and Remembers Deb Mueller Read More »
LBCA Welcomes Dr. Jason Mouabbi As New Scientific Advisory Board Chair
In August 2023, Jason Mouabbi, MD, assumed the role of chair of the Lobular Breast Cancer Alliance (LBCA) Scientific Advisory Board (SAB). Dr. Mouabbi is
LBCA Welcomes Dr. Jason Mouabbi As New Scientific Advisory Board Chair Read More »
Capucine Héraud, PhD, Awarded 2023 AACR-LBCA ILC Research Fellowship
The Lobular Breast Cancer Alliance (LBCA) is excited to announce Capucine Héraud, PhD, as the recipient of the 2023 AACR-LBCA Invasive Lobular Carcinoma (ILC) Research
Capucine Héraud, PhD, Awarded 2023 AACR-LBCA ILC Research Fellowship Read More »
Take LBCA’s Survey About ILC & Breast Surgery
The Lobular Breast Cancer Alliance Inc. is conducting a survey of individuals diagnosed with invasive lobular carcinoma (ILC) and their experiences with breast surgery. You
Take LBCA’s Survey About ILC & Breast Surgery Read More »
Q&A with Dr. Tali Amir: Using AI in the Imaging of ILC
The Lobular Breast Cancer Alliance (LBCA) recently posed questions to Tali Amir, MD, about her recent study A role for breast ultrasound Artificial Intelligence decision
Q&A with Dr. Tali Amir: Using AI in the Imaging of ILC Read More »
Highlighting Lobular Breast Cancer Research
A Letter from Our Executive Director May is National Cancer Research Month and a great time to highlight some of the recently published studies focusing
Highlighting Lobular Breast Cancer Research Read More »
LobularCard: Searching for Novel Germline Mutations in ILC Patients
Name of Trial/NCT#: LobularCard: Â NCT05410951 Summary: With this project we will aim to identify the frequency of 113 germline variants in lobular breast cancer patients.
LobularCard: Searching for Novel Germline Mutations in ILC Patients Read More »
LBCA Scientists Discuss Appropriate Use Criteria for FES/PET
Lobular Breast Cancer Alliance (LBCA) Scientific Advisory Board members Dr. Jason Mouabbi and Dr. Gary Ulaner were part of the recent process of the Society
LBCA Scientists Discuss Appropriate Use Criteria for FES/PET Read More »
Remembering LBCA Board Member Dr. Deb Mueller
Deborah (Deb) Lynn Mueller, MD, of San Antonio, Texas, wife, mother of two teenage daughters, prominent Trauma Surgeon and Critical Care Physician at UT Health
Remembering LBCA Board Member Dr. Deb Mueller Read More »
LBCA Accomplishments So Far in FY23 (since July 2022)
Last week the Lobular Breast Cancer Alliance (LBCA) released its Fiscal Year 2022 Annual Report, which features highlights of our accomplishments between July 1, 2021
LBCA Accomplishments So Far in FY23 (since July 2022) Read More »
ILC Science and Patient Advocacy Well Represented at SABCS22
Invasive lobular carcinoma (ILC) research and ILC patient advocates made their mark on this year’s San Antonio Breast Cancer Symposium (SABCS) held December 6 –
ILC Science and Patient Advocacy Well Represented at SABCS22 Read More »
LBCA Board Member Takes on Triathlon After Tackling ILC
On October 22, Tracy Cushing, MD, who was diagnosed with lobular breast cancer in 2021, took part in the inaugural Monarch Triathlon in Kingman, AZ.
LBCA Board Member Takes on Triathlon After Tackling ILC Read More »
Advocate Chat – Learning More About Cancer Data
A Conversation with Dr. Nadia Howlader from the National Cancer Institute (NCI) Surveillance Research Program On September 21, 2022, the Lobular Breast Cancer Alliance (LBCA)
Advocate Chat – Learning More About Cancer Data Read More »